Bluebird Bio Valuation
| BLUE Stock | USD 8.35 0.09 1.09% |
At this time, the firm appears to be undervalued. Bluebird bio shows a prevailing Real Value of $12.63 per share. The current price of the firm is $8.35. Our model approximates the value of Bluebird bio from analyzing the firm fundamentals such as Return On Equity of -1.87, shares outstanding of 9.72 M, and Operating Margin of (5.49) % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Bluebird Bio's valuation include:
Price Book 0.726 | Enterprise Value | Enterprise Value Ebitda (1.50) | Price Sales 1.4787 | Enterprise Value Revenue 7.1335 |
Undervalued
Today
Please note that Bluebird Bio's price fluctuation is risky at this time. Calculation of the real value of Bluebird bio is based on 3 months time horizon. Increasing Bluebird Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Bluebird stock is determined by what a typical buyer is willing to pay for full or partial control of Bluebird bio. Since Bluebird Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bluebird Stock. However, Bluebird Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.35 | Real 12.63 | Target 26.0 | Hype 8.21 |
The real value of Bluebird Stock, also known as its intrinsic value, is the underlying worth of Bluebird bio Company, which is reflected in its stock price. It is based on Bluebird Bio's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Bluebird Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Bluebird bio helps investors to forecast how Bluebird stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bluebird Bio more accurately as focusing exclusively on Bluebird Bio's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Bluebird Bio's intrinsic value based on its ongoing forecasts of Bluebird Bio's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Bluebird Bio's closest peers. If more than one evaluation category is relevant for Bluebird Bio we suggest using both methods to arrive at a better estimate.
Bluebird Bio Cash |
|
Bluebird Valuation Trend
Comparing Bluebird Bio's enterprise value against its market capitalization is a good way to estimate the value of Bluebird bio uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Bluebird Revenue by Product
Bluebird Bio Total Value Analysis
Bluebird bio is currently anticipated to have valuation of 378.93 M with market capitalization of 81.18 M, debt of 330.33 M, and cash on hands of 132.51 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Bluebird Bio fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
378.93 M | 81.18 M | 330.33 M | 132.51 M |
Bluebird Bio Investor Information
About 44.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.73. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bluebird bio has Price/Earnings To Growth (PEG) ratio of 0.32. The entity recorded a loss per share of 36.39. The firm had not issued any dividends in recent years. Bluebird Bio had 1:20 split on the 13th of December 2024. Based on the analysis of Bluebird Bio's profitability, liquidity, and operating efficiency, Bluebird bio is not in a good financial situation at this time. It has a very high odds of going through financial crisis in February.Bluebird Bio Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Bluebird Bio has an asset utilization ratio of 4.76 percent. This indicates that the Company is making $0.0476 for each dollar of assets. An increasing asset utilization means that Bluebird bio is more efficient with each dollar of assets it utilizes for everyday operations.Bluebird Bio Ownership Allocation
The market capitalization of Bluebird bio is $81.18 Million. 30% of Bluebird bio outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Bluebird Bio Profitability Analysis
The company reported the previous year's revenue of 29.5 M. Net Loss for the year was (211.91 M) with loss before overhead, payroll, taxes, and interest of (21.23 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Bluebird Bio's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Bluebird Bio and how it compares across the competition.
About Bluebird Bio Valuation
The stock valuation mechanism determines Bluebird Bio's current worth on a weekly basis. Our valuation model uses a comparative analysis of Bluebird Bio. We calculate exposure to Bluebird Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bluebird Bio's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -4.6 M | -4.4 M | |
| Pretax Profit Margin | (8.27) | (8.68) | |
| Operating Profit Margin | (9.52) | (10.00) | |
| Net Loss | (8.26) | (8.67) | |
| Gross Profit Margin | (0.12) | (0.13) |
Bluebird Bio Growth Indicators
Investing in growth stocks can be very risky. If the company such as Bluebird Bio does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 109.8 M |
Bluebird Bio Current Valuation Indicators
Valuation refers to the process of determining the present value of Bluebird bio and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Bluebird we look at many different elements of the entity such as Bluebird's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Bluebird Bio, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Bluebird Bio's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Bluebird Bio's worth.Complementary Tools for Bluebird Stock analysis
When running Bluebird Bio's price analysis, check to measure Bluebird Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluebird Bio is operating at the current time. Most of Bluebird Bio's value examination focuses on studying past and present price action to predict the probability of Bluebird Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluebird Bio's price. Additionally, you may evaluate how the addition of Bluebird Bio to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |